From October 1, 2023 to December 31, 2023, the company has repurchased 8,491,700 shares, representing 1.13% for CNY 48.35 million. With this, the company has completed the repurchase of 8,491,700 shares, representing 1.13% for CNY 48.35 million under the buyback announced on January 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.73 CNY | +0.21% | +1.94% | -14.47% |
1st Jan change | Capi. | |
---|---|---|
-14.47% | 457M | |
+20.70% | 43.77B | |
+28.38% | 22.83B | |
+18.68% | 14.34B | |
+54.86% | 12.96B | |
-0.05% | 6.79B | |
-11.65% | 6.41B | |
-8.87% | 5.73B | |
+12.21% | 5.69B | |
+9.49% | 4.75B |
- Stock Market
- Equities
- 603669 Stock
- News Lionco Pharmaceutical Group Co.,Ltd.
- Tranche Update on Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback Plan announced on January 31, 2023.